For foundations, family offices, and impact partners

Patient capital for patient science.

Deep tech is not built overnight. The companies that will define 2040 are being written in labs right now, by researchers who need a bridge to the market. We partner with funders who understand that the returns compound precisely because other people were not patient enough to try.

€60K per fellow, per year
50% co-funded by universities
10 – 15% equity retained per spin-out

The funding model

An evergreen flywheel for deep tech creation.

Your capital funds fellows. Fellows create spin-outs. Minority equity from those spin-outs compounds over a decade into a self-funding engine. Early cohorts are grant-backed. Later cohorts fund themselves.

💰

EU & national grants

EXIST, EIT programmes, Horizon Europe EIC Pathfinder, national innovation funds. Co-funding dramatically reduces capital intensity in the early cohorts.

🏗

SPRIND & public agencies

Germany's breakthrough innovation agency deploys over €220M annually, with instruments designed for exactly the kind of work we do. We are in active conversation with SPRIND and TransferAllianz.

🌟

Family offices & impact funds

Long-term partners who measure return in compounded impact, not quarterly IRR. We are looking for a small group of foundational funders for the first five cohorts.

Spin-out equity, retained

The Institute keeps a minority stake (10 to 15 percent) in every spin-out created through the programme. Successful exits fund future cohorts, in perpetuity.

🎓

University co-funding

Partners cover approximately half of each fellow's salary via a part-time research contract. Structural alignment, not a line-item cost.

💯

Structurally non-profit

Silverline Institute is a German gGmbH. We cannot distribute profits. Every euro returned to the Institute is reinvested into the next generation of fellows.

Why it has to be patient capital

The VC model does not fit deep tech. Something else has to.

7 – 10 years for a biotech to ship

Ten-year funds can’t wait ten years.

Today's VCs chase AI for a reason: fast returns, easily modelled. Deep tech is different by construction. A biotech company needs seven to ten years. A materials-science startup needs five to eight. Advanced manufacturing needs three to five just to prototype.

These timelines do not fit a ten-year fund with a three-year deployment window. So the capital does not show up, and the science sits in a drawer.

our time horizon

A different kind of vehicle.

The Institute succeeds when fellows succeed. Our alignment is structural, not contractual. We do not take board seats. We do not force exits. We hold minority equity and provide long-term support.

We are looking for partners who understand that the best things take time, and who want to be part of a project that compounds for thirty years.

Unit economics

What one fellow costs.

A deliberately simple structure, designed to be legible to a grant officer, a family office board, and a university treasurer in the same meeting.

€60K/year per fellow

Competitive compensation for an exceptional STEM graduate. Low enough to be fundable, high enough to be honest.

University 50%
Institute 50%
  • 💰
    ~€30K paid by the university

    Part-time scientific contract, direct to the fellow. Structural co-funding, not a cost line for us.

  • 📈
    ~€30K stipend from the Institute

    Brings the fellow to €60K total. Competitive with consulting offers, so the Triangle stops winning by default.

  • 🔎
    Programme overhead: ~€10 to 20K per fellow

    Commercial mentorship, bootcamps, events, tools, shared infrastructure. Shrinks per-fellow at scale.

  • Effective institute cost: €40 to 50K per fellow

    EU and national grant co-funding reduces this further. A typical cohort of 10 runs well under €500K of institute capital.

  • 🚀
    Return mechanism: 10 to 15% retained equity

    At scale, a modest spin-out rate creates a self-sustaining flywheel. Exits fund the next generation, not a GP carry.

Roadmap

From concept to compounding cohort.

Where we are, where we are going, and how your capital accelerates the specific step we are on.

Q2
2026 · Foundation

Incorporate the Institute.

Stand up the gGmbH, finalise the IP template, complete the map of European university innovation offices. Build the founding advisory board. Close first anchor funder.

  • gGmbH formation
  • IP template
  • Advisory board
  • Anchor funding
Q3
2026 · Partnerships

First university LOI.

Sign the founding partnership. Apply for EXIST and SPRIND support. Begin the fellow recruitment pipeline. Prove the model on paper before running it in a lab.

  • First LOI
  • EXIST / SPRIND
  • Fellow pipeline
Q4
2026 · Pilot

Three fellows in one lab.

Scouting-stage only. Small, tight, observable. The goal is learning, not scale. Document everything so the second cohort runs cleanly.

  • Pilot cohort
  • Scouting only
  • Full instrumentation
2027
First full programme

Full twelve-month cohort.

Five to eight fellows across two or three universities. First spin-outs emerging. Cross-university research exchange active. Begin raising a standing endowment from patient partners.

  • 5 to 8 fellows
  • Multi-university
  • First spin-outs
  • Endowment round

Ways to participate

Not every funder plays the same role.

We design the partnership around what you care about, over the time horizon you can commit to.

🌟

Anchor a cohort

Fund an entire cohort in your name or your foundation's. Early, visible, and formative for the Institute's direction.

Typical size €200K to €500K over twelve months.

You get direct access to the cohort, naming rights if desired, and a seat on the advisory board for the duration of the programme.

🎓

Sponsor a fellow

Fund a single fellow's stipend and programme costs. Lowest-friction way to back a specific researcher or topic area.

Typical size €40K to €50K for one fellow-year.

Ideal for smaller foundations, individual impact investors, or corporates who want to back deep tech without a commercial arrangement.

🏢

Join the endowment

A long-horizon partnership to build a standing endowment. The vehicle funds cohorts indefinitely from retained equity and annuities.

Horizon 10 years +, with spin-out equity participation.

For family offices and impact funds that want to be structural, not transactional. Terms co-designed, not templated.

The ask

Help us build the missing layer between European research and the companies it should become.

We are looking for foundational partners for cohorts one through three. If the thesis resonates, we would like an hour of your time. No deck, no pitch, just a conversation.

In formation, 2026. Talking with TU Berlin, TransferAllianz, and SPRIND. First pilot cohort planned for Q4 2026.